These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37387947)

  • 1. Retracted: The Application of Dopamine Combined with Intravenous Furosemide Infusion Therapy Has an Apparent Clinical Effect in Treating Patients with Heart Failure.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9854218. PubMed ID: 37387947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Application of Dopamine Combined with Intravenous Furosemide Infusion Therapy Has an Apparent Clinical Effect in Treating Patients with Heart Failure.
    Shi J; Wang R; Qin S; Zhang Z; Li H
    Evid Based Complement Alternat Med; 2022; 2022():1055160. PubMed ID: 36034940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine: The ROPA-DOP Trial.
    Sharma K; Vaishnav J; Kalathiya R; Hu JR; Miller J; Shah N; Hill T; Sharp M; Tsao A; Alexander KM; Gupta R; Montemayor K; Kovell L; Chasler JE; Lee YJ; Fine DM; Kass DA; Weiss RG; Thiemann DR; Ndumele CE; Schulman SP; Russell SD;
    JACC Heart Fail; 2018 Oct; 6(10):859-870. PubMed ID: 30098962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous infusion of furosemide combined with low-dose dopamine compared to intermittent boluses in acutely decompensated heart failure is less nephrotoxic and carries a lower readmission at thirty days.
    Aziz EF; Alviar CL; Herzog E; Cordova JP; Bastawrose JH; Pamidimukala CK; Tojino A; Park TS; Musat D; Kukin M
    Hellenic J Cardiol; 2011; 52(3):227-35. PubMed ID: 21642071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
    Cotter G; Weissgarten J; Metzkor E; Moshkovitz Y; Litinski I; Tavori U; Perry C; Zaidenstein R; Golik A
    Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial.
    Giamouzis G; Butler J; Starling RC; Karayannis G; Nastas J; Parisis C; Rovithis D; Economou D; Savvatis K; Kirlidis T; Tsaknakis T; Skoularigis J; Westermann D; Tschöpe C; Triposkiadis F
    J Card Fail; 2010 Dec; 16(12):922-30. PubMed ID: 21111980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of diuretic infusion clinic in preventing hospitalization for patients with decompensating heart failure.
    Alghalayini KW
    SAGE Open Med; 2020; 8():2050312120940094. PubMed ID: 32670579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial.
    Triposkiadis FK; Butler J; Karayannis G; Starling RC; Filippatos G; Wolski K; Parissis J; Parisis C; Rovithis D; Koutrakis K; Skoularigis J; Antoniou CK; Chrysohoou C; Pitsavos C; Stefanadis C; Nastas J; Tsaknakis T; Mantziari L; Giannakoulas G; Karvounis H; Kalogeropoulos AP; Giamouzis G
    Int J Cardiol; 2014 Mar; 172(1):115-21. PubMed ID: 24485633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Restoration of diuresis in the initial period of the oligoanuric stage of acute renal failure by dopamine-furosemide infusion].
    Razukas VA
    Ter Arkh; 1988; 60(6):42-3. PubMed ID: 3206367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine does not enhance furosemide-induced natriuresis in patients with congestive heart failure.
    Vargo DL; Brater DC; Rudy DW; Swan SK
    J Am Soc Nephrol; 1996 Jul; 7(7):1032-7. PubMed ID: 8829118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ventriculoarterial coupling changes on renal function, echocardiographic indices and energy efficiency in patients with acute decompensated systolic heart failure under furosemide and dopamine treatment: a comparison of three therapeutic protocols.
    Antoniou CK; Chrysohoou C; Lerakis S; Manolakou P; Pitsavos C; Tsioufis K; Stefanadis C; Tousoulis D
    Int J Cardiol; 2015 Nov; 199():44-9. PubMed ID: 26186629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mannitol, furosemide, and dopamine infusion in postoperative renal failure complicating cardiac surgery.
    Sirivella S; Gielchinsky I; Parsonnet V
    Ann Thorac Surg; 2000 Feb; 69(2):501-6. PubMed ID: 10735688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy of continuous furosemide and low-dose dopamine infusion in preeclampsia/eclampsia-related oliguria in the immediate postpartum period.
    Keiseb J; Moodley J; Connolly CA
    Hypertens Pregnancy; 2002; 21(3):225-34. PubMed ID: 12517329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of salt with low-dose furosemide and carperitide for treating acute decompensated heart failure: a single-center retrospective cohort study.
    Okuhara Y; Hirotani S; Ando T; Nishimura K; Orihara Y; Komamura K; Naito Y; Mano T; Masuyama T
    Heart Vessels; 2017 Apr; 32(4):419-427. PubMed ID: 27469321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous Infusion Versus Intermittent Boluses of Furosemide in Acute Heart Failure: A Systematic Review and Meta-Analysis.
    Chan JSK; Kot TKM; Ng M; Harky A
    J Card Fail; 2020 Sep; 26(9):786-793. PubMed ID: 31730917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure.
    Aaser E; Gullestad L; Tølløfsrud S; Lundberg J; Hall C; Djøseland O; Kjekshus J; Forfang K
    Scand J Clin Lab Invest; 1997 Jul; 57(4):361-7. PubMed ID: 9249883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety.
    Ng TM; Hshieh S; Chan CY; Elkayam U
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):373-81. PubMed ID: 22610091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous infusion vs. intermittent bolus injection of furosemide in acute decompensated heart failure: systematic review and meta-analysis of randomised controlled trials.
    Ng KT; Yap JLL
    Anaesthesia; 2018 Feb; 73(2):238-247. PubMed ID: 28940440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravenous furosemide for acute heart failure : continuous infusion or intermittent bolus ?].
    Dias J; Carballo S; Meyer P; Darbellay Farhoumand P; Agoritsas T
    Rev Med Suisse; 2022 Oct; 18(801):2004-2011. PubMed ID: 36314090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.